Radiotherapy of lung cancer: technology meets biology meets multidisciplinarity

Related Experiment Video

Updated: Jun 22, 2026

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

Michael Baumann, Daniel Zips, Steffen Appold

    Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
    |May 26, 2009
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
    07:53

    Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

    Published on: March 17, 2020

    Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
    08:34

    Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

    Published on: February 6, 2019

    Related Experiment Videos

    Last Updated: Jun 22, 2026

    Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
    08:17

    Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

    Published on: June 7, 2015

    Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
    07:53

    Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

    Published on: March 17, 2020

    Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
    08:34

    Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

    Published on: February 6, 2019

    Related Concept Videos

    Cancer Therapies02:49

    Cancer Therapies

    Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
    However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...

    Articles linked to this work by shared authors, journal, and citation graph.

    The crucial question: does adjuvant radiotherapy confer a survival benefit in pN1 oral squamous cell carcinoma (OSCC)? - A retrospective analysis.

    Oral and maxillofacial surgery·2026

    Organ Preservation and Quality of Life After Total Neoadjuvant Treatment in Rectal Cancer.

    JAMA network open·2026

    Combined re-radiation therapy and regional or capacitive hyperthermia as a part of multimodal treatment for locoregional breast cancer recurrences in previously irradiated areas.

    Radiation oncology (London, England)·2026

    Spinal leptomeningeal disease in patients with solid tumors: A single-center study on clinical presentation, diagnosis, treatment, and outcomes.

    Brain & spine·2026

    Acute toxicity and patient-reported quality of life during daily online adaptive radiotherapy versus conventional IGRT for localized prostate cancer: a prospective parallel cohort study.

    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2026

    Bridging to systemic therapy: PSMA-PET-based early and repetitive stereotactic body radiotherapy for nodal and bone oligo-recurrent prostate cancer.

    Frontiers in urology·2026

    Patient reported swallowing outcomes after prophylactic versus reactive gastrostomy during chemoradiotherapy for head and neck cancer: Results from the SwallPEG randomized trial.

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026

    ESTRO/EANO recommendation on reirradiation of glioblastoma.

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026

    Mind the data: pitfalls and perspectives in acquiring and interpreting preclinical evidence for the FLASH effect.

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026

    Photon FLASH spares radiation-induced lung injury and pulmonary hypertension in a preclinical model.

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026

    IAP inhibition enhances response to radiotherapy and chemotherapy in preclinical models of rectal cancer.

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026

    From contouring variability to dosimetric impact: a comprehensive assessment of online adaptive MR-guided SBRT for pancreatic cancer.

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026

    A cell-type resolved proton RBE model for potential clinical application.

    Medical physics·2026

    Three-fraction preoperative stereotactic radiotherapy for resectable brain metastases: the phase 2 STEP trial.

    Neuro-oncology·2026

    Adaptive MR-guided whole-pelvic SBRT with or without focal intraprostatic lesion boost for high-risk localized prostate Cancer: Adverse events and longitudinal quality-of-life outcomes.

    Clinical and translational radiation oncology·2026

    Development and validation of a cumulative risk model and assessment tool for radiation-induced hypothyroidism in head and neck cancer: a multicentre study.

    Clinical and translational radiation oncology·2026

    Radiation therapy quality assurance (RT QA) of adjuvant fractionated radiotherapy for WHO grade 2 atypical meningioma in the ROAM/EORTC1308 trial.

    Clinical and translational radiation oncology·2026

    Radiotherapy-induced oxidative stress and mitochondrial dysfunction: potential contributions of toxic elements and associated biomarkers-a systematic review.

    Frontiers in public health·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us